EFFECTIVENESS OF USING SULODEXIDE IN THE COMPLEX TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION WITH ACCOMPANYING DIABETES MELLITUS IN THE POST-COVID PERIOD

Abstract

Aim. To study the effectiveness of using sulodexide in the complex treatment of patients with arterial hypertension with accompanying diabetes in the post-COVID period. Methods. According to the inclusion criteria, 87 patients with hypertension and concomitanttype 2 diabetes participated in the study. Patients were included in the study after having COVID-19 at an average of 57.82±3.2 [46–112] days after the onset of infection. The first, main group, consisted of 45 patients who additionally used sulodexide capsules (250 LO twice a day for 3 weeks) against the background of the basic treatment of hypertension and diabetes. The second (control) group consisted of 44 patients, who received only the basic treatment of hypertension and diabetes. Results. It was established that the use of sulodexide (250 LO twice a day for 3 weeks) in the complex treatment of patients with hypertension and diabetes in the post-COVID period compared to the control group was accompanied by a reliable disappearance or reduction of the symptoms of the post-COVID syndrome, an additional decrease in blood pressure, a significant decrease in the ankle-brachial index, which indicated improvement in peripheral blood circulation and quality of life of these patients. Conclusions. Addition of sulodexide capsules to basic therapy in patients with hypertension and concomitant diabetes mellitus contributes to increasing the effectiveness of complex treatment, as evidenced by the reduction of symptoms of long post-COVID syndrome against the background of improvement in the course of comorbid pathology, improvement in the quality of life of patients.